AIMS/HYPOTHESIS: Recent studies have suggested resveratrol (RSV) as a new natural therapeutic agent to treat type 2 diabetes and lipid-induced insulin resistance. Here, we investigated whether RSV could reverse palmitate-induced insulin resistance in human primary muscle cells. METHODS: Myotubes obtained from six healthy men (54 ± 3 years (mean ± SE), BMI 25.0 ± 1.7 kg/m(2), fasting plasma glucose concentration (fP-glucose) 5.47 ± 0.09 mmol/l) were treated for 4 h with 100 μmol/l RSV and/or 0.2 mmol/l palmitate, and stimulated with or without 100 nmol/l insulin. Assays of glucose uptake, glycogen synthesis, palmitate oxidation, intracellular signalling and AMP-activated protein kinase (AMPK) activity were performed. RESULTS: RSV did not reverse palmitate-induced impairment of glucose metabolism. Surprisingly, RSV decreased glucose uptake and glycogen synthesis in human skeletal muscle cells. Palmitate oxidation and phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase β (ACCβ) were inhibited by RSV, and RSV completely blocked the activity of AMPK isoform complexes α1/β2/γ1 and α2/β2/γ1 in in-vitro kinase activity assays. Endoplasmic reticulum (ER) stress was increased in response to RSV, as indicated by increased phosphorylation of eukaryotic initiation factor 2α (eIF2α) and increased expression of CCAAT/enhancer binding protein homologous protein (CHOP). CONCLUSIONS/ INTERPRETATION: Acute exposure to RSV inhibits AMPK activity, fatty-acid oxidation and glucose metabolism in human myotubes.
AIMS/HYPOTHESIS: Recent studies have suggested resveratrol (RSV) as a new natural therapeutic agent to treat type 2 diabetes and lipid-induced insulin resistance. Here, we investigated whether RSV could reverse palmitate-induced insulin resistance in human primary muscle cells. METHODS: Myotubes obtained from six healthy men (54 ± 3 years (mean ± SE), BMI 25.0 ± 1.7 kg/m(2), fasting plasma glucose concentration (fP-glucose) 5.47 ± 0.09 mmol/l) were treated for 4 h with 100 μmol/l RSV and/or 0.2 mmol/l palmitate, and stimulated with or without 100 nmol/l insulin. Assays of glucose uptake, glycogen synthesis, palmitate oxidation, intracellular signalling and AMP-activated protein kinase (AMPK) activity were performed. RESULTS:RSV did not reverse palmitate-induced impairment of glucose metabolism. Surprisingly, RSV decreased glucose uptake and glycogen synthesis in human skeletal muscle cells. Palmitate oxidation and phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase β (ACCβ) were inhibited by RSV, and RSV completely blocked the activity of AMPK isoform complexes α1/β2/γ1 and α2/β2/γ1 in in-vitro kinase activity assays. Endoplasmic reticulum (ER) stress was increased in response to RSV, as indicated by increased phosphorylation of eukaryotic initiation factor 2α (eIF2α) and increased expression of CCAAT/enhancer binding protein homologous protein (CHOP). CONCLUSIONS/ INTERPRETATION: Acute exposure to RSV inhibits AMPK activity, fatty-acid oxidation and glucose metabolism in human myotubes.
Authors: Sung-Jun Park; Faiyaz Ahmad; Andrew Philp; Keith Baar; Tishan Williams; Haibin Luo; Hengming Ke; Holger Rehmann; Ronald Taussig; Alexandra L Brown; Myung K Kim; Michael A Beaven; Alex B Burgin; Vincent Manganiello; Jay H Chung Journal: Cell Date: 2012-02-03 Impact factor: 41.582
Authors: Karim Bouzakri; Reginald Austin; Anna Rune; Michael E Lassman; Pablo M Garcia-Roves; Joel P Berger; Anna Krook; Alexander V Chibalin; Bei B Zhang; Juleen R Zierath Journal: Diabetes Date: 2008-02-26 Impact factor: 9.461
Authors: Lasse Gliemann; Jakob Friis Schmidt; Jesper Olesen; Rasmus Sjørup Biensø; Sebastian Louis Peronard; Simon Udsen Grandjean; Stefan Peter Mortensen; Michael Nyberg; Jens Bangsbo; Henriette Pilegaard; Ylva Hellsten Journal: J Physiol Date: 2013-07-22 Impact factor: 5.182
Authors: Marcus M Seldin; Simon Koplev; Prashant Rajbhandari; Laurent Vergnes; Gregory M Rosenberg; Yonghong Meng; Calvin Pan; Thuy M N Phuong; Raffi Gharakhanian; Nam Che; Selina Mäkinen; Diana M Shih; Mete Civelek; Brian W Parks; Eric D Kim; Frode Norheim; Karthickeyan Chella Krishnan; Yehudit Hasin-Brumshtein; Margarete Mehrabian; Markku Laakso; Christian A Drevon; Heikki A Koistinen; Peter Tontonoz; Karen Reue; Rita M Cantor; Johan L M Björkegren; Aldons J Lusis Journal: Cell Metab Date: 2018-05-01 Impact factor: 27.287
Authors: Jesper Olesen; Stine Ringholm; Maja M Nielsen; Christina T Brandt; Jesper T Pedersen; Jens F Halling; Laurie J Goodyear; Henriette Pilegaard Journal: Exp Gerontol Date: 2013-08-03 Impact factor: 4.032